Picture of Inhalation Sciences Sweden AB logo

ISAB Inhalation Sciences Sweden AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Inhalation Sciences Initiates Study To Validate Preciseinhale For Clinical Use

May 23 (Reuters) - Inhalation Sciences Sweden AB  ISAB.TE :
    * INHALATION SCIENCES AB (PUBL) INITIATES STUDY TO VALIDATE
PRECISEINHALE FOR CLINICAL USE
    * TECHNICAL AND REGULATORY VALIDATION IS EXPECTED TO TAKE
ABOUT 15
MONTHS
    * CLINICAL VALIDATION STUDY AIMS FOR BOTH TECHNICAL AND
REGULATORY
VALIDATION OF PRECISEINHALE FOR USE IN CLINICAL STUDIES OF
INHALABLE SUBSTANCES
    * TECHNICAL AND REGULATORY VALIDATION WILL BE FULLY FINANCED
THROUGH DIVESTMENT OF A SMALL PART OF ISAB'S HOLDINGS IN ZICCUM
AB

Source text for Eikon:  ID:nWkr77Dvg0 
Further company coverage:  ISAB.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Inhalation Sciences Sweden AB

See all news